Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000159139 | SCV000209083 | uncertain significance | not provided | 2013-05-21 | criteria provided, single submitter | clinical testing | The S1110W missense substitution has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Server reports S1110W was not observed in approximately 6,500 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. S1110W is a non-conservative amino acid substitution as a polar Serine residue is replaced with a non-polar Tryptophan residue at a position that is well conserved across species. Additionally, in silico algorithms predict S1110W is a damaging change. However, the S1110W variant is not located within any known functional domain of the protein and mutations associated with Noonan syndrome have not been reported in the literature beyond codon Proline 894. Therefore, the S1110W missense change is likely a rare benign variant; however, the possibility that is a disease-causing mutation cannot be excluded. The variant is found in SOS1 panel(s). |
Ambry Genetics | RCV002321669 | SCV002609055 | uncertain significance | Cardiovascular phenotype | 2021-12-23 | criteria provided, single submitter | clinical testing | The p.S1110W variant (also known as c.3329C>G), located in coding exon 20 of the SOS1 gene, results from a C to G substitution at nucleotide position 3329. The serine at codon 1110 is replaced by tryptophan, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV002467628 | SCV002763228 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467627 | SCV002763229 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV002516397 | SCV003023894 | likely benign | RASopathy | 2023-11-08 | criteria provided, single submitter | clinical testing |